Other
Acquired Intangible Amortization
Bristol-Myers Squibb Acquired Intangible Amortization decreased by 47.1% to $437.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 47.3%, from $830.00M to $437.00M. Over 4 years (FY 2021 to FY 2025), Acquired Intangible Amortization shows a downward trend with a -24.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementIncome Statement
SectionOther
CategoryProfitability
SignalLower is better
VolatilityStable
First reportedQ1 2017
Last reportedQ1 2026Apr 30, 2026
How to read this metric
High amortization reflects significant past M&A activity; it reduces reported earnings but does not impact cash flow.
Detailed definition
This metric represents the systematic allocation of the cost of intangible assets, such as patents and acquired product...
Peer comparison
Standard for companies with significant acquisition-led growth strategies.
Metric ID:
other_amortizationof_acquired_intangible_assetsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.55B | $2.55B | $2.42B | $2.42B | $2.42B | $2.42B | $2.34B | $2.26B | $2.26B | $2.26B | $2.28B | $2.36B | $2.42B | $2.41B | $1.69B | $830.00M | $830.00M | $831.00M | $826.00M | $437.00M |
| QoQ Change | — | -0.0% | -5.1% | +0.0% | +0.0% | +0.0% | -3.1% | -3.7% | +0.0% | -0.0% | +1.0% | +3.5% | +2.5% | -0.4% | -29.6% | -51.0% | +0.0% | +0.1% | -0.6% | -47.1% |
| YoY Change | — | — | — | — | -5.1% | -5.0% | -3.1% | -6.7% | -6.6% | -6.7% | -2.8% | +4.5% | +7.0% | +6.6% | -25.7% | -64.8% | -65.6% | -65.5% | -51.2% | -47.3% |
Range$437.00M – $2.55B
CAGR-31.0%
Avg YoY Growth-21.1%
Median YoY Growth-6.6%
Current Streak2 quarters decline
Acquired Intangible Amortization at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's acquired intangible amortization?
- Bristol-Myers Squibb (BMY) reported acquired intangible amortization of $437.00M in Q1 2026.
- How has Bristol-Myers Squibb's acquired intangible amortization changed year-over-year?
- Bristol-Myers Squibb's acquired intangible amortization decreased by 47.3% year-over-year, from $830.00M to $437.00M.
- What is the long-term trend for Bristol-Myers Squibb's acquired intangible amortization?
- Over 4 years (2021 to 2025), Bristol-Myers Squibb's acquired intangible amortization has grown at a -24.2% compound annual growth rate (CAGR), from $10.02B to $3.32B.
- What does acquired intangible amortization mean?
- The annual non-cash expense of writing down the value of acquired patents and licenses.